文献速递慢阻肺

慢阻肺患者的慢性咳嗽:一项基于人群的队列研究

Chronic Cough in Individuals With COPD: A Population-Based Cohort Study.
PubMed 文献 · Chest · 2020-01-25

在哥本哈根普通人群研究的43,271名成人嵌套队列中,8,181人(19%)患有慢阻肺,其中796人(10%)合并慢性咳嗽。合并慢性咳嗽的慢阻肺患者呼吸道症状更多、医疗资源使用更多、肺功能更低、血液炎症生物标志物更高,提示慢性咳嗽是疾病更严重的标志。

要点

  • 慢阻肺患者中慢性咳嗽患病率为10%。
  • 合并慢性咳嗽者症状负担和医疗使用显著更高。
  • 合并慢性咳嗽者肺功能更低且全身炎症更明显。

核心结论

  • 慢阻肺患者合并慢性咳嗽与更严重的疾病相关,表现为更多呼吸道症状和医疗资源使用、更低的肺功能以及更高的血液炎症水平。

研究设计与样本

  • 基于哥本哈根普通人群研究(CGPS)的嵌套队列研究,纳入43,271名成人,识别慢阻肺和慢性咳嗽患者,记录呼吸道症状、医疗资源使用、肺功能和血液炎症生物标志物。

主要发现

  • 在43,271名普通人群个体中,8,181人(19%)患有慢阻肺,其中796人(10%)有慢性咳嗽。
  • 合并慢性咳嗽的慢阻肺患者莱斯特咳嗽问卷中位总分17.7(16.0-18.9),生理领域5.9(5.3-6.3),心理领域5.6(4.9-6.3),社会领域6.3(5.8-6.8)。
  • 合并慢性咳嗽者相比无慢性咳嗽者更常出现咳痰(60% vs 8%)、喘息(46% vs 14%)、呼吸困难(66% vs 38%)、胸痛/胸闷(9% vs 4%)、夜间呼吸困难(8% vs 3%)。
  • 合并慢性咳嗽者过去10年急性支气管炎/肺炎发作史(45% vs 25%)和过去12个月≥3次全科医生就诊(53% vs 37%)的比例更高。
  • 合并慢性咳嗽者FEV1%预计值更低(81% vs 89%),FEV1/FVC更低(0.64 vs 0.66),血液高敏C反应蛋白、纤维蛋白原、白细胞、中性粒细胞、嗜酸性粒细胞和IgE水平更高。

临床怎么用

  • 在慢阻肺管理中应评估慢性咳嗽,因其提示更严重的症状负担和医疗资源使用。
  • 对合并慢性咳嗽的慢阻肺患者应关注肺功能下降和全身炎症,加强综合管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The role and impact of chronic cough in individuals with COPD have not been described in the general population. This study hypothesized that comorbid chronic cough is a marker of disease severity in individuals with COPD. METHODS: This study identified individuals with COPD and chronic cough, and recorded respiratory symptoms, health-care utilizations, lung function, and inflammatory biomarkers in blood in a nested cohort of 43,271 adults from the Copenhagen General Population Study (CGPS). RESULTS: Among 43,271 individuals from the general population, 8,181 (19%) experienced COPD, of whom 796 (10%) had chronic cough. Individuals with COPD and chronic cough had a Leicester Cough Questionnaire median (25th-75th percentiles) total score of 17.7 (16.0-18.9), corresponding to 5.9 (5.3-6.3) for the physical domain, 5.6 (4.9-6.3) for the psychological domain, and 6.3 (5.8-6.8) for the social domain. Among individuals with COPD, those with chronic cough vs those without chronic cough more often experienced sputum production (60% vs 8%), wheezing (46% vs 14%), dyspnea (66% vs 38%), chest pain/tightness (9% vs 4%), nighttime dyspnea (8% vs 3%), episodes of acute bronchitis/pneumonias in the last 10 years (45% vs 25%), and ≥ 3 general practitioner visits in the past 12 months (53% vs 37%). Furthermore, these individuals had lower FEV1 % predicted (81% vs 89%) and FEV1/FVC (0.64 vs 0.66), as well as higher levels of high-sensitivity C-reactive protein, fibrinogen, leukocytes, neutrophils, eosinophils, and IgE in blood. CONCLUSIONS: Comorbid chronic cough in individuals with COPD is associated with a more severe disease in terms of more respiratory symptoms and health-care utilizations, lower lung function, and increased inflammation in blood.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Landt E, Çolak Y, Lange P, et al. Chronic Cough in Individuals With COPD: A Population-Based Cohort Study. Chest. 2020. PMID: 31987882. doi:10.1016/j.chest.2019.12.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。